Marijuana: risks of its legalization
Keywords:
MEDICAL MARIJUANA, DOSE-RESPONSE RELATIONSHIP, DRUG, DIAGNOSIS.Abstract
Introduction: marijuana is the most widely used illicit drug in the world. At present, its therapeutic effects are being rediscovered and in some countries its legalization is projected, divulging its benignity and benefits.
Objectives: to present the specialized criteria reflecting the Cuban position and the formulation of recommendations.
Method: logical-dialectical and historical from experiences and search of updated scientific information of international reputation.
Results: the campaign in favor of legalization is represented by people of good will and high ethical values; their professional profiles limit the understanding of the repercussion that can result for young people, adolescents, families and communities with accessibility of marijuana licit consumption, falling into interpretations impregnated with good will and risks of catastrophic significance for health. It demonstrates the lack of scientific support and clinical evidence to justify these campaigns, experiences, preventive positions and problems arising from the consumption of illicit drugs, especially marijuana.
Conclusions: the abuse of hard drugs is opposed to the Comprehensive Mental Health, a principle supported by institutions and authors of recognized prestige, positions from which the most frequent propaganda advertisements that support the convenience of legalization are collected, to conclude, formulating the values of judgment that demonstrate the absence of medical justification regarding these recommendations. The need for a healthy, scientific and ethical position that closes the ways to opportunism and to the not socially justified interests by the expected benefit starts.
Downloads
References
1. González Menéndez, RA. Marihuana: beneficios vs grandes riesgos. Reflexiones sobre las tendencias legalizadoras. Revista Anales de la Academia de Ciencias de Cuba [Internet] 2016 [citado 2017 dic 24]; 6(2). Disponible en: http://www.revistaccuba.cu/index.php/acc/article/view/506
2. Ecohotado, A Historia General de las drogas. Madrid. Editorial Espasa Calpe. S.A. 1998.
3. González, R. Terapéutica Psiquiátrica Integral, La Habana, Editorial Ciencias Médicas, 2009
4. Argudín M.J. Compasividad. Manejo Psicoterapéutico. La Habana, Edit. Científico Técnica, 2015
5. Lorenzo P, Ladero J, Leza J, Lizasoain I. Drogodependencias: Farmacología, Patología, Psicología, legislación. Madrid, Editora Panamericana, 1999.
6. Organización Mundial de la Salud (OMS) Informe de situación regional sobre el alcohol y la Salud en las Américas. Washington, DC. OPS. 2015. Disponible en http://iris.paho.org/xmlui/bitstream/handle/123456789/7708/9789275318553_esp.pdf
7. OMS. Neurociencia del consumo y dependencia de sustancias psicoactivas. Washington D.C. OPS. 2005. [citado 2017 dic 24] Disponible en: http://www.who.int/substance_abuse/publications/neuroscience_spanish.pdf
8. González, R. Las adicciones a la Luz de la Ciencia y el símil, La Habana, Editora Política, 2009
9. Alonso Fernández, F. Alcoholdependencia. Madrid. Masson Salvat, 1998.
10. Volkow N D., Baler, R.D., Wilson, M., Compton, MD., Susan R.B., Weiss, Ph.D. Adverse Health Effects of Marijuana Use. N Engl J Med. [Internet]. 2014 [citado 2017 dic 24]; 370(23):2219-27. Disponible en: https://www.nejm.org/doi/pdf/10.1056/NEJMra1402309
11. Alonso F, Esteban C, Montoro L, Tortosa F. Psychotropic substances and driving: prevalence and types. Annals of General Psychiatry. 2014[citado 2017 dic 24]; 13: 14. https://annals-general-psychiatry.biomedcentral.com/track/pdf/10.1186/1744-859X-13-14
12. González, R. Donaire, I, Alcohol y otras drogas. 100 preguntas y respuestas, La Habana. Editorial Academia. La Habana. 2015.
13. Smith LA, Azariah F, Lavender VTC, Stoner NS, Bettiol S. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database of Systematic Reviews. 2015 [citado 2017 dic 24]; (11). Disponible en: http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD009464.pub2/abstract;jsessionid=CCBB3510DCC77633792A3AFABC3EEF4E.f01t04
14. Walitt B, Klose P, Fitzcharles M, Phillips T, Häuser W. Cannabinoids for fibromyalgia. Cochrane Database Syst Rev. 2016 Jul [citado 2017 dic 24]; (7). Disponible en: http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD011694.pub2/pdf/standard
15. Lutge EE, Gray A, Siegfried N. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS. Cochrane Database of Systematic Reviews. 2013 Apr [citado 2017 dic 24]; (4). Disponible en: http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD005175.pub3/pdf/standard
16. Hermosilla K. 9 beneficios médicos de la marihuana que podrían hacerte ir por ella a la farmacia. NUEVAMUJER. 2013[Internet]. 2013 Jul [citado 2017 dic 24]. Disponible en: https://www.nuevamujer.com/bienestar/2013/07/02/9-beneficios-medicos-de-la-marihuana-que-podrian-hacerte-ir-por-ella-a-la-farmacia.html
17. Moore E; Mancuso SG; Slade T; Galletly C; Castle DJ. The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis. Aust. N. Z. J. Psychiatry [Internet]; 2012 [citado 2017 dic 24]; 46(9): 864-78. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/22472772
18. UNODC. Informe mundial sobre las drogas. Resumen, conclusiones y consecuencias en materias de políticas. 2017: 1-36. https://www.unodc.org/wdr2017/field/WDR_Booklet1_Exsum_Spanish.pdf
19. National Institute on Drug Abuse. ¿Qué es la marihuana medicinal?. 2017 [citado 2017 dic 24]. Disponible en: https://www.drugabuse.gov/es/publicaciones/drugfacts/la-marihuana-como-medicina
20. McLoughlin BC, Pushpa-Rajah JA, Gillies D, Rathbone J, Variend H, Kalakouti E, Kyprianou K. Cannabis and schizophrenia. Cochrane Database of Systematic Reviews [Internet]; 2014 [citado 2017 dic 24]; (10). Disponible en: http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD004837.pub3/full
21. Mills, C. Approaches to Substance Abuse in Cuba. Medicc Review, [Internet]. 2013 Oct [citado 2017 dic 24]; 15(4): 6-10. Disponible en: http://www.scielosp.org/pdf/medicc/v15n4/03.pdf
22. ONUDC. Informe Mundial sobre las Drogas. 2016. https://www.unodc.org/doc/wdr2016/WDR_2016_ExSum_spanish.pdf
23. González Menéndez RA. Los rubros "casi" olvidados de las drogas duras. Rev Hosp Psiquiátrico de la Habana [Internet]. 2014 [citado 2014 Abr 20]; 11(1): [aprox. 2 p.]. Disponible en: http://www.revistahph.sld.cu/rev%20nro1-2014/hph%20contrib%202.html
24. Llorca Hernández BC, García Leyva M. Diagnóstico del uso indebido de drogas. Premisas para su prevención. III Jornada de Educación Médica. Habana 2013 [Internet]. 2013 [citado 2013 Jul 22]: [aprox. 11 p.]. Disponible en: http://edumedhabana2013.sld.cu/index.php/edumedhabana/2013/paper/view/336/125
25. Ministerio de Salud Pública. Problemas a resolver por el médico general integral básico y su nivel de actuación. La Habana: Instituto Superior de Ciencias Médicas de La Habana; 2010.
26. Rodríguez Méndez M, Echemendía Tocabens B. La prevención en salud: posibilidad y realidad. Rev Cubana Hig Epidemiol [Internet]. 2011 Ene [citado 2013 Jul 27]; 49(1): [aprox. 15 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-30032011000100015

Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/